(Q81194314)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18449341%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

review article

1 reference

title

The medical management of primary sclerosing cholangitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18449341%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

main subject

sclerosing cholangitis

1 reference

primary sclerosing cholangitis

inferred from title

1 reference

Anthony Michaels

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18449341%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Cynthia Levy

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18449341%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

12 March 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18449341%20AND%20SRC:MED&resulttype=core&format=json

Medscape journal of medicine

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18449341%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18449341%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18449341%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18449341%20AND%20SRC:MED&resulttype=core&format=json

Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis?

6 January 2020

cites work

1 reference

12 December 2020

A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial

1 reference

12 December 2020

Mycophenolate mofetil for the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Therapeutic benefit of sulfasalazine for patients with primary sclerosing cholangitis

1 reference

12 December 2020

Combined Therapy with Azathioprine, Prednisolone, and Ursodiol in Patients with Primary Sclerosing Cholangitis: A Case Series

1 reference

12 December 2020

Medical treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group

1 reference

12 December 2020

Oral budesonide in the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

An open-label pilot trial of cladibrine (2-cholordeoxyadenosine) in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

12 December 2020

No beneficial effects of transdermal nicotine in patients with primary sclerosing cholangitis: results of a randomized double-blind placebo-controlled cross-over study

1 reference

12 December 2020

Primary biliary cirrhosis and primary sclerosing cholangitis

1 reference

12 December 2020

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

1 reference

12 December 2020

Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'.

1 reference

12 December 2020

A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis

1 reference

12 December 2020

Pirfenidone in the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Management of primary sclerosing cholangitis

1 reference

12 December 2020

Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats

1 reference

12 December 2020

Beneficial effect of bezafibrate on primary sclerosing cholangitis (three case reports).

1 reference

12 December 2020

Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis

1 reference

12 December 2020

Efficacy of bezafibrate in a patient with primary sclerosing cholangitis

1 reference

12 December 2020

Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey

1 reference

12 December 2020

A pilot study of etanercept in the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Fluvoxamine for fatigue in primary biliary cirrhosis and primary sclerosing cholangitis: a randomised controlled trial [ISRCTN88246634]

1 reference

12 December 2020

Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis

1 reference

12 December 2020

Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.

1 reference

12 December 2020

Fatigue in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Azathioprine treatment in primary sclerosing cholangitis

1 reference

12 December 2020

Non-smoking: a feature of ulcerative colitis

1 reference

12 December 2020

Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis?

1 reference

12 December 2020

Prospective trial of penicillamine in primary sclerosing cholangitis

1 reference

12 December 2020

Ursodeoxycholic acid for chronic liver diseases

1 reference

12 December 2020

Effect of different doses of ursodeoxycholic acid in chronic liver disease

1 reference

12 December 2020

Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid

1 reference

12 December 2020

Ursodeoxycholic acid for primary sclerosing cholangitis

1 reference

12 December 2020

The combination of prednisone and colchicine in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Treatment of primary sclerosing cholangitis with oral methotrexate

1 reference

12 December 2020

Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study.

1 reference

12 December 2020

[Bezafibrate alone is an effective first-line therapy for primary sclerosing cholangitis: a case report]

1 reference

12 December 2020

Primary sclerosing cholangitis: summary of a workshop

1 reference

12 December 2020

Mycophenolate mofetil for the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

1 reference

12 December 2020

Primary sclerosing cholangitis: epidemiology, natural history, and prognosis

1 reference

12 December 2020

The medical management of primary sclerosing cholangitis

1 reference

12 December 2020

Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study.

1 reference

12 December 2020

Sertraline as a first-line treatment for cholestatic pruritus

1 reference

12 December 2020

Tacrolimus for the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Depression in patients with primary biliary cirrhosis and primary sclerosing cholangitis

1 reference

12 December 2020

The incidence of cholangiocarcinoma in primary sclerosing cholangitis after long-time treatment with ursodeoxycholic acid.

1 reference

12 December 2020

Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial

1 reference

12 December 2020

A double-blind controlled trial of oral-pulse methotrexate therapy in the treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period

1 reference

12 December 2020

Successful treatment of primary sclerosing cholangitis with cyclosporine and corticosteroid

1 reference

12 December 2020

Tacrolimus (FK 506), a treatment for primary sclerosing cholangitis: results of an open-label preliminary trial

1 reference

12 December 2020

Colchicine treatment of primary sclerosing cholangitis

1 reference

12 December 2020

Serum lipid and fat-soluble vitamin levels in primary sclerosing cholangitis

1 reference

12 December 2020

Primary sclerosing cholangitis is associated with nonsmoking: a case-control study.

1 reference

12 December 2020

Risk of primary sclerosing cholangitis is associated with nonsmoking behavior

1 reference

12 December 2020

Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study.

1 reference

12 December 2020

Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period.

1 reference

12 December 2020

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

1 reference

12 December 2020

Review article: the management of primary sclerosing cholangitis

1 reference

12 December 2020

Efficacy of ursodeoxycholic acid treatment and endoscopic dilation of major duct stenoses in primary sclerosing cholangitis. An 8-year prospective study

1 reference

12 December 2020

Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses

1 reference

12 December 2020

Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progression.

1 reference

12 December 2020

Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study

1 reference

12 December 2020

Identifiers

1 reference